High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.

被引：0
|
作者：
Mitchell, SA
Bansi, D
Hunt, N
Christie, J
Fleming, K
Chapman, R
机构：
[1] JOHN RADCLIFFE HOSP, DEPT GASTROENTEROL, OXFORD OX3 9DU, ENGLAND
[2] JOHN RADCLIFFE HOSP, NUFFIELD DEPT PATHOL, OXFORD OX3 9DU, ENGLAND
来源：
GUT | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：TH115 / TH115
页数：1
相关论文
共 50 条
  • [11] Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
    Färkkilä, M
    Karvonen, AL
    Nurmi, H
    Nuutinen, H
    Taavitsainen, M
    Pikkarainen, P
    Kärkkäinen, P
    HEPATOLOGY, 2004, 40 (06) : 1379 - 1386
  • [12] URSODEOXYCHOLIC ACID (UDCA) THERAPY FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) - PRELIMINARY-REPORT OF A RANDOMIZED CONTROLLED TRIAL
    VANTHIEL, DH
    WRIGHT, HI
    GAVALER, JS
    HEPATOLOGY, 1992, 16 (04) : A62 - A62
  • [13] A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis
    Hommes, Daan W.
    Erkelens, Willernien
    Ponsioen, Cyriel
    Stokkers, Pieter
    Raws, Erik
    van der Spek, Miram
    Ten Kate, Fiebo
    van Deventer, Sander J.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (05) : 522 - 526
  • [14] High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
    Leuschner, Ulrich F. H.
    Lindenthal, Birgit
    Herrmann, Guenter
    Arnold, Joachim C.
    Roessle, Martin
    Cordes, Hans-Joerg
    Zeuzem, Stefan
    Hein, Jasper
    Berg, Thomas
    HEPATOLOGY, 2010, 52 (02) : 472 - 479
  • [15] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS
    COMBES, B
    CARITHERS, RL
    MADDREY, WC
    LIN, DY
    MCDONALD, MF
    WHEELER, DE
    EIGENBRODT, EH
    MUNOZ, SJ
    RUBIN, R
    GARCIATSAO, G
    BONNER, GF
    WEST, AB
    BOYER, JL
    LUKETIC, VA
    SHIFFMAN, ML
    MILLS, AS
    PETERS, MG
    WHITE, HM
    ZETTERMAN, RW
    ROSSI, SS
    HOFMANN, AF
    MARKIN, RS
    HEPATOLOGY, 1995, 22 (03) : 759 - 766
  • [16] THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Larusso, N. F.
    Bowlus, C. L.
    Levy, C.
    Vuppalanchi, R.
    Floreani, A.
    Andreone, P.
    Srestha, R.
    Trotter, J.
    Goldberg, D.
    Rushbrook, S.
    Hirschfield, G. M.
    Van Biene, C.
    Penceck, R.
    Macconell, L.
    David, S.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E67 - E67
  • [17] The AESOP Trial: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Obeticholic Acid in Patients with Primary Sclerosing Cholangitis
    Kowdley, Kris V.
    Bowlus, Christopher L.
    Levy, Cynthia
    Vuppalanchi, Raj
    Floreani, Annarosa
    Andreone, Pietro
    LaRusso, Nicholas F.
    Shrestha, Roshan
    Trotter, James
    Goldberg, David S.
    Rushbrook, Simon
    Hirschfield, Gideon M.
    Van Biene, Courtney
    Pencek, Richard
    MacConell, Leigh
    Shapiro, David
    HEPATOLOGY, 2017, 66 (06) : 1254A - 1255A
  • [18] Venlafaxine in fibromyalgia: Results of a randomized, placebo-controlled, double-blind trial.
    Zijlstra, TR
    Barendregt, PJ
    van De Laar, MAF
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S105 - S105
  • [19] Efficacy Trial of All-trans Retinoic Acid (ATRA) in combination with Ursodeoxycholic Acid (UDCA) in Primary Sclerosing Cholangitis (PSC)
    Assis, David N.
    Abdelghany, Osama
    Cai, Shi-Ying
    Gossard, Andrea A.
    Eaton, John E.
    Keach, Jill C.
    Deng, Yanhong
    Nkinin, Stephenson W.
    Setchell, Kenneth D. R.
    Ciarleglio, Maria
    Lindor, Keith D.
    Boyer, James L.
    HEPATOLOGY, 2014, 60 : 346A - 347A
  • [20] Ursodeoxycholic acid (UDCA) for primary sclerosing cholangitis (PSC): Results of a 2-year randomized controlled trial evaluating single versus multiple daily doses
    vanHoogstraten, HJF
    vandeMeeberg, PC
    Wolfhagen, FHJ
    Kuiper, H
    Hop, WCJ
    vanBergeHenegouwen, GP
    Schalm, SW
    vanBuuren, HR
    HEPATOLOGY, 1997, 26 (04) : 1089 - 1089
12345